These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2717454)

  • 21. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
    Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
    Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
    [No Abstract]   [Full Text] [Related]  

  • 22. Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis.
    Pond MN; Newport M; Joanes D; Conway SP
    Eur Respir J; 1994 Sep; 7(9):1640-4. PubMed ID: 7995394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temocillin in cystic fibrosis: a retrospective pilot study.
    Kent L; Bradley JM; France M; Döring G; Carryn S; Bradbury I; Rendall J; Jones A; Elborn JS
    J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
    Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
    Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Up-date on the antibiotic treatment of pulmonary infection in cystic fibrosis].
    Cobos Barroso N
    An Esp Pediatr; 1993 Oct; 39 Suppl 55():195-9. PubMed ID: 8291800
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pulmonary infections in cystic fibrosis: pathogenesis and therapy].
    Götz M
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):718-25. PubMed ID: 3934527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Consensus conference: home intravenous antibiotic treatment for cystic fibrosis. The Sira Carrasco Foundation. 26 April 2002].
    Salcedo A; Girón RM; Beltrán B; Martínez A; Máiz L; Suárez L;
    Arch Bronconeumol; 2003 Oct; 39(10):469-75. PubMed ID: 14533997
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravenous antibiotic therapy in cystic fibrosis: in hospital or at home?
    Peckham D; Knox A
    Respir Med; 1993 Jul; 87(5):329-30. PubMed ID: 8209051
    [No Abstract]   [Full Text] [Related]  

  • 29. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
    Faruqi S; McCreanor J; Moon T; Meigh R; Morice AH
    Int J Antimicrob Agents; 2008 Nov; 32(5):461-3. PubMed ID: 18703318
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
    Stelmach I; Korzeniewska A; Stelmach W
    Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Macrolides, Pseudomonas aeruginosa and cystic fibrosis].
    Guillot M; Amiour M; El Hachem C; Harchaoui S; Ribault V; Paris C
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S48-50. PubMed ID: 17370396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary infections in cystic fibrosis.
    Acta Paediatr Scand Suppl; 1982; 301():1-132. PubMed ID: 6963850
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Gappa M; Steinkamp G; Tümmler B; von der Hardt H
    Scand J Gastroenterol Suppl; 1988; 143():74-6. PubMed ID: 3164515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
    Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
    Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior.
    Proesmans M; Heyns L; Moons P; Havermans T; De Boeck K
    Respir Med; 2009 Feb; 103(2):244-50. PubMed ID: 18848441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Strategy of antibiotic therapy in the course of chronic Pseudomonas aeruginosa infection].
    Bassinet L
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S118-28. PubMed ID: 12910144
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.
    Bauernfeind A; Hörl G; Przyklenk B
    Scand J Gastroenterol Suppl; 1988; 143():99-102. PubMed ID: 3164518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal analysis of FEV1 changes related to antibiotic therapy in children with cystic fibrosis.
    Javadpour S; Jones A; Brownlee K
    Ir Med J; 2007; 100(7):529-32. PubMed ID: 17886526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis, intravenous antibiotics, and home therapy.
    Hammond LJ; Caldwell S; Campbell PW
    J Pediatr Health Care; 1991; 5(1):24-30. PubMed ID: 1990112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problems of antibiotic therapy in mucoviscidosis].
    Steinitz H
    Z Allgemeinmed; 1972 Aug; 48(24):1085-9. PubMed ID: 4649651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.